Time trends in ischemic stroke among type 2 diabetic and non-diabetic patients: Analysis of the Spanish national hospital discharge data (2003-2012)

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Munoz Rivas, Nuria ^a   Mendez Bailon, Manuel ^b   Hernandez Barrera, Valentin ^c   De Miguel Yanes, Jose Ma ^d   Jimenez Garcia, Rodrigo ^c   Esteban Hernandez, Jesus ^c   Jimenez Trujillo, Isabel ^c   Alvaro Meca, Alejandro ^c   Carrasco Garrido, Pilar ^c   De Miguel Diez, Javier ^d   Lopez De Andres, Ana ^c  

^a HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c UNIVERSIDAD REY JUAN CARLOS   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CHARLSON COMORBIDITY INDEX; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; FEMALE; FIBRINOLYSIS; GENDER; HOSPITAL; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; ICD-9; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL PROCEDURES; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SPAIN; THERAPEUTIC PROCEDURE; TREND STUDY; ADOLESCENT; COMPLICATION; MIDDLE AGED; STROKE; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT DISCHARGE; SPAIN; STROKE; YOUNG ADULT;

EID: 84958025944     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0145535     Document Type: Article

References (56)

1. Bejot Y, Benatru I, Rouaud O, Fromont A, Besancenot JP, Moreau T, et al.: . Epidemiology of stroke in Europe: Geographic and environmental differences. J Neurol Sci 2007; 262: 85-88. PMID: 17761197
2. López AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ: Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet 2006; 367: 1747-1757. PMID: 16731270
3. Grysiewicz RA, Thomas K, Pandey DK: . Epidemiology of Ischemic and Hemorrhagic Stroke: Incidence, Prevalence, Mortality, and Risk Factors. Neurol Clin. 2008; 26: 871-895. doi: 10.1016/j.ncl.2008.07. 003 PMID: 19026895
4. Luitse MJ, Biessels GJ, Rutten G E, Kappelle LJ: Diabetes, hyperglycaemia, and acute ischaemic stroke. Lancet Neurol 2012; 11: 261-271. doi: 10.1016/S1474-4422(12)70005-4 PMID: 22341034
5. Idris I, Thomson GA, Sharma JC: Diabetes mellitus and stroke. Int J Clin Pract 2006; 60: 48-56. PMID: 16409428
6. Banerjee C, Moon YP, Paik MC, Rundek T, Mora-McLaughlin C, Vieira JR, et al. Duration of diabetes and risk of ischemic stroke: The Northern Manhattan Study. Stroke 2012; 43: 1212-1217. doi: 10.1161/STROKEAHA.111.641381 PMID: 22382158
7. Eriksson M, Carlberg B, Eliasson M: The disparity in long-term survival after a fi rst stroke in patients with and without diabetes persists: The Northern Sweden MONICA study. Cerebrovasc Dis 2012; 34: 153-160. doi: 10.1159/000339763 PMID: 22907276
8. Shah AD, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-Rodriguez M, Gale CP, et al. Type 2 diabetes and incidence of cardiovascular diseases: A cohort study in 1.9 million people. Lancet Diabetes Endocrinol 2015; 3: 105-113. doi: 10.1016/S2213-8587(14)70219-0 PMID: 25466521
9. Instituto Nacional de Estadística. Defunciones según la causa de muerte 2011 [Available: Http://www. ine.es].
10. Marrugat J, Arboix A, García-Eroles L, Salas T, Vila J, Castell C, Tresserras R, et al.: The estimated incidence and case fatality rate of ischemic and hemorrhagic cerebrovascular disease in 2002 in Catalonia. Rev Esp Cardiol 2007; 60: 573-580. PMID: 17580045
11. Brea A, Laclaustra M, Martorell E, Pedragosa A. Epidemiología de la enfermedad vascular cerebral en España. Clin Invest Arterioscl 2013; 25: 211-217.
12. Díaz-Guzman J, Egido-Herrero JA, Gabriel-Sanchez R, Barberà G, Fuentes B, Fernández-Pérez C, et al.: Incidencia de ictus en España. Bases metodológicas del estudio Iberictus. Rev Neurol 2008; 47: 617-623. PMID: 19085876
13. Vega T, Zurriaga O, Ramos JM, Gil M, Alamo R, Lozano JE, et al. Stroke in Spain: Epidemiologic incidence and patterns; a health sentinel network study. J Stroke Cerebrovasc Dis 2009; 18: 11-16. doi: 10.1016/j.jstrokecerebrovasdis.2008.06.010 PMID: 19110138
14. Díaz-Guzmán J, Egido JA, Gabriel-Sánchez R, Barberá-Comes G, Fuentes-Gimeno B, Fernández- Pérez C: . Stroke and tran-sient ischemic attack incidence rate in Spain: The IBERICTUS Study. Cerebrovasc Dis 2012; 34: 272-281. doi: 10.1159/000342652 PMID: 23095851
15. American Diabetes Association: Standards of Medical Care in Diabetes 2013. Diabetes Care 2013; 36: S11-66. doi: 10.2337/dc13-S011 PMID: 23264422
16. Nwaneri C, Cooper H, Bowen-Jones D: Mortality in type 2 diabetes mellitus. Magnitude of the evidence from a systematic review and meta-analysis. Br J Diab Vasc Dis 2013; 13: 192-207.
17. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V: Worldwide stroke incidence and early case fatality reported in 56 population-based studies: A systematic review. Lancet Neurol 2009; 8: 355-369. doi: 10.1016/S1474-4422(09)70025-0 PMID: 19233729
18. Instituto Nacional de Gestión Sanitaria, Ministerio de Sanidad, Servicios Sociales e Igualdad: Conjunto Mínimo Básico de Datos, Hospitales del INSALUD. [Available: Http://www.ingesa.msc.es/estadEstudios/documPublica/CMBD-2001.htm].
19. Ministerio de Sanidad, Servicios Sociales e Igualdad: Encuesta Nacional de Salud de España. [Available: Http://www.msssi.gob.es/estadEstudios/estadisticas/encuestaNacional/].
20. Soriguer F, Goday A, Bosch-Comas A, Bordiú E, Calle-Pascual A, Carmena R, et al: Prevalence of diabetes mellitus and impaired glucose regulation in Spain: The Di@bet.es Study. Diabetologia 2012; 55: 88-93 doi: 10.1007/s00125-011-2336-9 PMID: 21987347
21. Instituto Nacional de Estadística: Population estimates 2010. [Available: Http://www.ine.es].
22. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40: 373-383. PMID: 3558716
23. Thomsen RW, Nielsen JS, Ulrichsen SP, Pedersen L, Hansen AM, Nilsson T: The Danish Centre for Strategic Research in Type 2 Diabetes (DD2) study: Collection of baseline data from the first 580 patients. Clin Epidemiol 2012; 4: 43-48. doi: 10.2147/CLEP.S30083 PMID: 23071401
24. Brea A, Laclaustra M, Martorell E, Pedragosa A: Epidemiología de la enfermedad vascular cerebral en España. Clin Invest Arterioscl 2013; 25: 211-217.
25. Feigin VL, Krishnamurthi RV, Barker-Collo S, McPherson KM, Barber PA, Parag V, et al. 30-Year Trends in Stroke Rates and Outcome in Auckland, New Zealand (1981-2012): A Multi-Ethnic Population- Based Series of Studies. PLoS ONE 2015; 10: E0134609. doi: 10.1371/journal.pone.0134609 PMID: 26291829
26. Giampaoli S, Palmieri L, Donfrancesco C, Lo Noce C, Pilotto L, Vanuzzo D, et al. Cardiovascular health in Italy. Ten-year surveillance of cardiovascular diseases and risk factors: Osservatorio Epidemiologico Cardiovascolare/Health Examination Survey 1998-2012. Eur J PrevCardiol2015; 22: 937.
27. Vasiliadis A V, Zikic M: Current status of stroke epidemiology in Greece: A panorama. Neurol Neurochir Pol 2014; 48: 449-457. doi: 10.1016/j.pjnns.2014.11.001 PMID: 25482257
28. Rodríguez T, Malvezzi M, Chatenoud L, Bosetti C, Levi F, Negri E, et al. Trends in mortality from coronary heart and cerebrovascular diseases in the Americas: 1970-2000. Heart 2006; 92: 453-60. PMID: 16537758
29. Cayuela A, Cayuela L, Escudero-Martínez I, Rodríguez-Domínguez S, González A, Moniche F, et al. Análisis de las tendencias en la mortalidad por enfermedades cerebrovasculares en España 1980- 2011. Neurología n.d.
30. Emerging Risk Factors Collaboration, Sarwar N, Gao P, Seshasai Sr, Gobin R, Kaptoge S, Di Angelantonio E, et al.: Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375: 2215-2222. doi: 10.1016/S0140-6736(10)60484-9 PMID: 20609967
31. Garcia JT, Robles LR: Epidemiology of stroke in patients with diabetes. Av Diabetol 2010; 26: 397-402.
32. Banerjee C, Moon YP, Paik MC, Rundek T, Mora-McLaughlin C, Vieira JR, et al. Duration of diabetes and risk of ischemic stroke: The Northern Manhattan Study. Stroke 2012; 43: 1212-1217. doi: 10.1161/STROKEAHA.111.641381 PMID: 22382158
33. Javier Basterra-Gortari F, Bes-Rastrollo M, Seguí-Gómez M, Forga L, Alfredo Martínez J, Angel Martínez- González M. Tendencias de la obesidad, diabetes mellitus, hipertensión e hipercolesterolemia en España (1997-2003). Medicina Clínica 2007; 129: 405-8. PMID: 17927933
34. Arboix A, Cartanyà A, Lowak M, García-Eroles L, Parra O, Oliveres M, et al. Gender differences and woman-specific trends in acute stroke: Results from a hospital-based registry (1986-2009). Clin Neurol Neurosurg 2014; 127: 19-24. doi: 10.1016/j.clineuro.2014.09.024 PMID: 25459238
35. Abellán J, Ruilope LM, Leal M, Armario P, Tiberio G, Martell N: Control de los factores de riesgo cardiovascular en pacientes con ictus atendidos en Atención Primaria en España. EstudioICTUSCARE. Med Clin 2011; 136: 329-335.
36. Palacios S, Mc Clure LA, Benavente OR, Bazan C 3rd, Pergola P, Hart RG. Lacunar Strokes in patients with diabetes mellitus: Risk factors, infarct location, and prognosis, : The secondary prevention of small subcortical strokes study. Stroke.2014 Sept; 45(9): 2689-94 doi: 10.1161/STROKEAHA.114.005018 PMID: 25034716
37. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, et al.: . Guidelines for the primary prevention of stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42: 517-584. doi: 10.1161/STR.0b013e3181fcb238 PMID: 21127304
38. Marini C, Carolei A: Epidemiology of stroke in the young. Stroke 2003; 34: E13. PMID: 12702842
39. Peters SA, Huxley RR, Woodward M: Diabetes as a risk factor for stroke in women compared with men: A systematic review and meta-analysis of 64 cohorts, including 775 385 individuals and 12 539 strokes. Lancet 2014; 383: 1973-1980. doi: 10.1016/S0140-6736(14)60040-4 PMID: 24613026
40. Stevens RJ, Coleman RL, Adler A, Stratton IM, Matthews DR, Holman RR: Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66. Diabetes Care 2004; 27: 201-207. PMID: 14693990
41. Howard BV, Cowan LD, Go O, Welty TK, Robbins DC, Lee ET: Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study. Diabetes Care 1998; 21: 1258-1265. PMID: 9702430
42. Evans RW, Orchard TJ: Oxidized lipids in insulin-dependent diabetes mellitus: A sex-diabetes interaction?. Metabolism 1994; 43: 1196-1200. PMID: 8084294
43. Steinberg HO, Paradisi G, Cronin J, Crowde K, Hempfling A, Hook G, et al. Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation 2000; 101: 2040-2046. PMID: 10790344
44. Mansfield MW, Heywood DM, Grant PJ: Sex diff erences in coagulation and fi brinolysis in white subjects with non-insulindependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996; 16: 160-164. PMID: 8548417
45. Wannamethee SG, Papacosta O, Lawlor DA, Whincup PH, Lowe GD, Ebrahim S, et al.: Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women's Heart Health Study. Diabetologia 2012; 55: 80-87. doi: 10.1007/s00125-011-2284-4 PMID: 21861177
46. Jimenez Caballero PE, Lopez Espuela F Portilla Cuenca JC, Ramirez Moreno JM, Pedrera Zamorano JD, Casado Naranjo I: Charlson comorbidity index in ischemic stroke and intracerebral hemorrhage as predictor of mortality and functional outcome after 6 months. J Stroke Cerebrovasc Dis 2013; 22: 214-218.
47. Icks A, Claessen H, Morbach S, Glaeske G, Hoffmann F. Time-dependent impact of diabetes on mortality in patients with stroke: Survival up to 5 years in a health insurance population cohort in Germany. Diabetes Care. 2012; 35: 1868-75 doi: 10.2337/dc11-2159 PMID: 22688543
48. IST-3 collaborative group. Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial. Lancet Neurology 2013; 12: 768-776.
49. Wardlaw JM, del Zoppo G, Yamaguchi T, Berge E: Thrombolysis for acute ischaemic stroke. Cochrane Database System Rev 2009;3CD000213.
50. Strbian D, Sairanen T, Meretoja A, Pitkaniemi J, Putaala J, Salonen O, et al. Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis. Neurology 2011; 77: 341-348. doi: 10.1212/WNL.0b013e3182267b8c PMID: 21715707
51. Khalessi A.A., Natarajan S.K, Orion D., Binning M.J., Siddiqui A., Levy E.I et al., 2011. Acute Stroke Intervention. JACC: Cardiovascular Interventions, 4(3), : 261-269. doi: 10.1016/j.jcin.2010.11.015 PMID: 21435602
52. Whiteley WN, Slot KB, Fernandes P, Sandercock P, Wardlaw J: Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: A systematic review and meta-analysis of 55 studies. Stroke 2012; 43: 2904-2909. doi: 10.1161/STROKEAHA.112.665331 PMID: 22996959
53. Zhang PL, Wang YX, Chen Y, Zhang CH, Li CH, Dong Z, et al.: Analysis on the correlation factors for hemorrhagic transformation after intravenous thrombolytic therapy. Eur Rev Med Pharmacol Sci 2015; 19: 1001-1008. PMID: 25855925
54. Lindley RI, Wardlaw JM, Whiteley WN, Cohen G, Blackwell L, Murray GD, et al. Alteplase for acute ischemic stroke outcomes by clinically important subgroups in the Third International Stroke Trial. Stroke 2015; 46: 746-756. doi: 10.1161/STROKEAHA.114.006573 PMID: 25613308
55. Lopez-de-Andres A, Jimenez-García R, Hernandez-Barrera V, Perez-Farinos N, de Miguel-Yanes JM, Mendez-Bailon M, et al National trends in utilization and outcomes of coronary revascularization procedures among people with and without type 2 diabetes in Spain (2001-2011). Cardiovasc Diabetol 2014: 13: 3. doi: 10.1186/1475-2840-13-3 PMID: 24383412
56. Ramalle-Gomara E, Ruiz E, Serrano M, Bártulos M, González M-A, Matute B. Hospital discharges and mortality registries: 2 complementary databases for the epidemiological surveillance of stroke. J Stroke Cerebrovasc Dis. noviembre de 2013; 22(8): E441-5.